JVMTX
Price
$30.35
Change
-$0.19 (-0.62%)
Updated
Sep 20 closing price
TRVHX
Price
$18.82
Change
-$0.12 (-0.63%)
Updated
Sep 20 closing price
Ad is loading...

JVMTX vs TRVHX

Header iconJVMTX vs TRVHX Comparison
Open Charts JVMTX vs TRVHXBanner chart's image
JHancock Disciplined Value Mid Cap R4
Price$30.35
Change-$0.19 (-0.62%)
VolumeN/A
CapitalizationN/A
Nuveen Mid Cap Value I
Price$18.82
Change-$0.12 (-0.63%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
JVMTX vs TRVHX Comparison Chart
Loading...
VS
JVMTX vs. TRVHX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JVMTX is a Buy and TRVHX is a StrongBuy.

FUNDAMENTALS
Fundamentals
JVMTX has more cash in the bank: 23.4B vs. TRVHX (1.82B). TRVHX pays higher dividends than JVMTX: TRVHX (1.41) vs JVMTX (0.73). JVMTX was incepted earlier than TRVHX: JVMTX (11 years) vs TRVHX (9 years). TRVHX is a more actively managed with annual turnover of: 78.00 vs. JVMTX (41.00). JVMTX has a lower initial minimum investment than TRVHX: JVMTX (0) vs TRVHX (100000). TRVHX annual gain was more profitable for investors over the last year : 26.14 vs. JVMTX (19.27). JVMTX return over 5 years is better than : 43.64 vs. TRVHX (-1.67).
JVMTXTRVHXJVMTX / TRVHX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence11 years9 years-
Gain YTD11.01014.47776%
Front LoadN/AN/A-
Min. Initial Investment0100000-
Min. Initial Investment IRAN/AN/A-
Net Assets23.4B1.82B1,284%
Annual Yield % from dividends0.731.4152%
Returns for 1 year19.2726.1474%
Returns for 3 years13.38-2.44-549%
Returns for 5 years43.64-1.67-2,614%
Returns for 10 years63.34N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ALVR0.78-0.01
-0.85%
AlloVir
LEA108.02-2.00
-1.82%
Lear Corp
RWAY10.13-0.24
-2.31%
Runway Growth Finance Corp
SLNO51.50-1.23
-2.33%
Soleno Therapeutics
TIVC0.27-0.01
-3.57%
Tivic Health Systems